Merck KGaA signs potential $1 billion deal with UK biotech
June 5, 2017Sales and Marketing F-star, Merck KGaA
UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …
Latest prostate cancer research could provide boost for J&J
June 5, 2017Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer
Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
New targeted therapy promises strong response rate across 17 cancer types
June 5, 2017Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology
Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
Breakthrough treatment for ovarian cancer displays promising results
June 5, 2017Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer
A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …
Tau pathology as the key to understanding Alzheimer’s disease
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …
Abbvie names new General Managers for UK and France
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment
Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …
Research provides clues about Zika virus damage to foetal brains
June 2, 2017Research and Development India, Zika, Zika virus
The Zika virus has been documented since 1947 and was first discovered to have infected a human in 1952. The …
ABPI appoints new Executive Director of Government Affairs
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI
The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer
June 2, 2017Medical Communications, Research and Development AstraZeneca, lynparza
New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …
Old antibiotic offers potential cost-effective MS treatment
June 2, 2017Medical Communications, Research and Development Myelin, multiple sclerosis
The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …
Top Ten most popular articles on Pharmafile.com this week
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
NICE U-turns to recommend Sanofi Gaucher disease drug
June 2, 2017Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi
It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …
Childhood mortality from diarrhoea falls by third
June 2, 2017Medical Communications Diarhhoea, India, Nigeria
A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …
Clinical Trial Success: How Relationships Are Key
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros
Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Silence Therapeutics instate new COO
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics
Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Europe vs USA: New drug approvals
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs
Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …
What the life sciences industry wants from the next UK government
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences
The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
New method discovered to target chronic pain
June 1, 2017Research and Development opioid, painkillers
Chronic pain is notoriously difficult to treat and can lead some people to take painkillers of increasing strength to combat …
Mylan overcharged for EpiPen by $1.7 billion, new report says
June 1, 2017Sales and Marketing Mylan, epipen
More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the …
New biosimilar guidelines launched in the EU
June 1, 2017Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars
A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
